Category: Ethics

When Will We See More Gender Equality in Investing?

In many spheres, such as politics, media and entertainment, women have made considerable progress in reaching executive leadership positions, achieving higher pay, and building new enterprises. But this ascent hasn’t been achieved everywhere. In my own industry, investing, progress has been painfully slow. Read the full article in The Harvard Business Review


CNBC: Why drug prices are so difficult to bring down

This article was originally posted by Kari Firestone’s newest article discusses why the incentives for companies and research organizations may not be aligned with customers’ desire for lower drug prices. Additionally, the legal complexity of the Medicare system leaves the government with no negotiating power, further inflating prescription drug prices. Read the full article…


NYT: A Drug Costs $272,000 a Year. Not So Fast, Says New York State.

It’s time for courts to weigh in on the issue of drug pricing.  As an investor, we want drug companies to earn a strong return on their investment – but using the “value of a life” thesis to justify price is too arbitrary as that might be infinite. Read the full article in The New…